Extended panels (on request)

HER2 (ERBB2) mRNA

Breast and gastric cancer, supplementary marker

Clinical area
Extended panels (on request)
Method
mRNA expression (RT-qPCR)
Sample
FFPE tissue block
Report languages
EN · AR · RU

About this test

Quantifies ERBB2 (HER2) mRNA expression in tumour tissue by RT-qPCR. It is a supplementary result: treatment decisions rely on validated immunohistochemistry (IHC) and in situ hybridisation (ISH), which this test does not replace.

When to order

As an additional data point alongside IHC/ISH when the clinician or pathologist requests it.

Available assays

  • HER2 expression analysis kitmRNA expression (RT-qPCR)

Offered on request. Current guidelines give this test a limited role in routine practice; results are reported as genotype or expression data for the ordering clinician to interpret.

Results are reported to the ordering physician and should be interpreted in clinical context.

Request this test

Offer this test to your patients.

Contract pricing and turnaround times are provided on request for laboratories and clinics.